Over the weekend and the beginning of this week, patients may have seen or heard news stories similar to this: “Strict rules as GPs start to prescribe weight loss jab Mounjaro”.
The practice would like to ask patients with any queries regarding the Mounjaro injection to not contact the practice at this time. The Hampshire and IOW (HIOW) integrated care board (ICB) have released the following messaging:
Currently across NHS Hampshire and Isle of Wight, which includes Portsmouth and Southampton, neither semaglutide (Wegovy) or tirzepatide (Mounjaro) injections are available for managing weight loss and obesity.
From 23 June, people living with obesity will be able to begin accessing tirzepatide (Mounjaro®) for weight loss purposes in primary care settings. This does not mean prescriptions will be provided immediately. It means primary care settings can begin discussions with patients about whether tirzepatide is the right option to improve their health through weight loss.
In Hampshire and the Isle of Wight around 1,000 people currently qualify for the medication based on national eligibility criteria – we are working to set up services quickly however this it will not be available locally until later this year (Autumn) – so please don’t contact your GP just yet as they’re unable to help currently. We will update this webpage when we have more information.
NHS weight loss support :: NHS Hampshire and Isle of Wight
If you would like to access information about weight loss and discuss weight loss services available to you (excluding the new proposed Mounjaro injections), please do continue to contact the practice as usual.